DL-Arginine
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

7200-25-1DL-Arginine

● In Stock

Catalogue No.:VL6870007
CAS No.:7200-25-1
Mol. Formula:C6H14N4O2
Mol. Weight:174.20 g/mol

Additional information on CAS 7200-25-1

Parent drug

Arginine

IUPAC Name

2-amino-5-(diaminomethylideneamino)pentanoic acid

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Smile

O=C(O)C(N)CCCNC(N)=N

Inchl

InChI=1S/C14H25ClN6O5/c15-6-10(22)8(2-1-5-19-14(17)18)20-7-12(24)21-9(13(25)26)3-4-11(16)23/h8-9,20H,1-7H2,(H2,16,23)(H,21,24)(H,25,26)(H4,17,18,19)/t8?,9-/m0/s3

Description

The compound L-Arginine L-Aspartate is a thoroughly characterized reference standard that complies with rigorous regulatory guidelines, including those from USP, EMA, JP, and BP. It is ideal for critical applications such as analytical method development, method validation (AMV), and quality control (QC), especially in the production of Arginine. Designed to support both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA), this product delivers the precision required for reliable results. Additionally, it includes a detailed Structure Elucidation Report (SER), ensuring accuracy and dependability for advanced analytical purposes. DL-Arginine(CAS No: 7200-25-1) or 2-amino-5-(diaminomethylideneamino)pentanoic acid. it is used for the treatment and prevention of cell division, and wound healing. it is also used for the treatment of cardiovascular disease which is l arginine gets converted into a chemical i.e.nitric oxide causes improved blood vessels.

References

Loesche, W. J., et al. “Comparison of the Benzoyl-DL-Arginine-Naphthylamide (BANA) Test, DNA Probes, and Immunological Reagents for Ability to Detect Anaerobic Periodontal Infections due to Porphyromonas Gingivalis, Treponema Denticola, and Bacteroides Forsythus.” Journal of Clinical Microbiology, vol. 30, no. 2, 1992, pp. 427–33, https://doi.org/10.1128/jcm.30.2.427-433.1992.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url